{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:28:04Z","timestamp":1791494884927,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04270-8","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:03:00Z","timestamp":1730970180000},"page":"801-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Artificial intelligence algorithms enhance urine cytology reporting confidence in postoperative follow-up for upper urinary tract urothelial carcinoma"],"prefix":"10.1007","volume":"57","author":[{"given":"Cheng-Che","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ri","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Shun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jiuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hung","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"14","key":"4270_CR1","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.1002\/cam4.6084","volume":"12","author":"YH Chang","year":"2023","unstructured":"Chang YH et al (2023) Trends and sex-specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study. Cancer Med 12(14):15350\u201315357","journal-title":"Cancer Med"},{"issue":"1","key":"4270_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL et al (2021) Cancer Statistics, 2021. CA Cancer J Clin 71(1):7\u201333","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4270_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.urolonc.2020.01.008","volume":"38","author":"T van Doeveren","year":"2020","unstructured":"van Doeveren T et al (2020) Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review Urol Oncol 38(6):590\u2013598","journal-title":"A systematic review Urol Oncol"},{"issue":"2","key":"4270_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/iju.14731","volume":"29","author":"MY Lin","year":"2022","unstructured":"Lin MY et al (2022) Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001\u20132010). Int J Urol 29(2):121\u2013127","journal-title":"Int J Urol"},{"issue":"5","key":"4270_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.aogh.2014.10.002","volume":"80","author":"D Hashim","year":"2014","unstructured":"Hashim D, Boffetta P (2014) Occupational and environmental exposures and cancers in developing countries. Ann Glob Health 80(5):393\u2013411","journal-title":"Ann Glob Health"},{"key":"4270_CR6","doi-asserted-by":"publisher","first-page":"1408793","DOI":"10.1155\/2020\/1408793","volume":"2020","author":"YC Huang","year":"2020","unstructured":"Huang YC, Chen YH (2020) Cancer incidence characteristic evolution based on the National Cancer Registry in Taiwan. J Oncol 2020:1408793","journal-title":"J Oncol"},{"issue":"4","key":"4270_CR7","first-page":"355","volume":"16","author":"SH Lamm","year":"2003","unstructured":"Lamm SH et al (2003) Bladder cancer and arsenic exposure: differences in the two populations enrolled in a study in southwest Taiwan. Biomed Environ Sci 16(4):355\u2013368","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"4270_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1023\/A:1023905900171","volume":"14","author":"YC Chen","year":"2003","unstructured":"Chen YC et al (2003) Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14(4):303\u2013310","journal-title":"Cancer Causes Control"},{"issue":"1","key":"4270_CR9","doi-asserted-by":"publisher","first-page":"8373","DOI":"10.1038\/s41598-021-87770-2","volume":"11","author":"BY Hsiao","year":"2021","unstructured":"Hsiao BY et al (2021) Ensemble forecasting of a continuously decreasing trend in bladder cancer incidence in Taiwan. Sci Rep 11(1):8373","journal-title":"Sci Rep"},{"key":"4270_CR10","doi-asserted-by":"publisher","first-page":"204209862199772","DOI":"10.1177\/2042098621997727","volume":"12","author":"YC Kang","year":"2021","unstructured":"Kang YC et al (2021) Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies. Ther Adv Drug Saf 12:2042098621997727","journal-title":"Ther Adv Drug Saf"},{"key":"4270_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003255","author":"JS Chen","year":"2016","unstructured":"Chen JS et al (2016) Chronic kidney disease is associated with upper tract urothelial carcinoma. Medicine. https:\/\/doi.org\/10.1097\/MD.0000000000003255","journal-title":"Medicine"},{"issue":"2","key":"4270_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","volume":"46","author":"W Oosterlinck","year":"2004","unstructured":"Oosterlinck W et al (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46(2):147\u2013154","journal-title":"Eur Urol"},{"issue":"4","key":"4270_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.eururo.2008.01.006","volume":"53","author":"R Zigeuner","year":"2008","unstructured":"Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53(4):720\u2013731","journal-title":"Eur Urol"},{"issue":"6","key":"4270_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","volume":"67","author":"T Seisen","year":"2015","unstructured":"Seisen T et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67(6):1122\u20131133","journal-title":"Eur Urol"},{"issue":"8","key":"4270_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","volume":"20","author":"TW Flaig","year":"2022","unstructured":"Flaig TW et al (2022) NCCN guidelines(R) insights: bladder cancer, version 2.2022. J Natl Compr Canc Netw 20(8):866\u2013878","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"4270_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","volume":"4","author":"E Laukhtina","year":"2021","unstructured":"Laukhtina E et al (2021) Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur Urol Oncol 4(6):927\u2013942","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"4270_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0090-4295(02)02136-2","volume":"61","author":"Y Lotan","year":"2003","unstructured":"Lotan Y, Roehrborn CG (2003) Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology 61(1):109\u2013118","journal-title":"Urology"},{"issue":"11","key":"4270_CR18","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/cncy.22615","volume":"130","author":"YC Ou","year":"2022","unstructured":"Ou YC et al (2022) Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: a pilot study. Cancer Cytopathol 130(11):872\u2013880","journal-title":"Cancer Cytopathol"},{"key":"4270_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpi.2023.100346","volume":"15","author":"JF Hang","year":"2024","unstructured":"Hang JF et al (2024) Comparative evaluation of slide scanners, scan settings, and cytopreparations for digital urine cytology. J Pathol Inform 15:100346","journal-title":"J Pathol Inform"},{"issue":"4","key":"4270_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/1097-0142(20000825)90:4<222::AID-CNCR4>3.0.CO;2-A","volume":"90","author":"AA Renshaw","year":"2000","unstructured":"Renshaw AA (2000) Subclassifying atypical urinary cytology specimens. Cancer 90(4):222\u2013229","journal-title":"Cancer"},{"issue":"2","key":"4270_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jasc.2021.12.003","volume":"11","author":"EM Wojcik","year":"2022","unstructured":"Wojcik EM, Kurtycz DFI, Rosenthal DL (2022) We\u2019ll always have Paris The Paris system for reporting urinary cytology 2022. J Am Soc Cytopathol 11(2):62\u201366","journal-title":"J Am Soc Cytopathol"},{"issue":"2","key":"4270_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/jpm12020170","volume":"12","author":"IP Nikas","year":"2022","unstructured":"Nikas IP et al (2022) The Paris System for Reporting Urinary Cytology: A Meta-Analysis. J Pers Med 12(2):170","journal-title":"J Pers Med"},{"issue":"10","key":"4270_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/dc.24561","volume":"48","author":"DFI Kurtycz","year":"2020","unstructured":"Kurtycz DFI, Sundling KE, Barkan GA (2020) The Paris system of reporting urinary cytology: strengths and opportunities. Diagn Cytopathol 48(10):890\u2013895","journal-title":"Diagn Cytopathol"},{"key":"4270_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.892067","volume":"10","author":"SH Jeong","year":"2022","unstructured":"Jeong SH, Ku JH (2022) Urinary markers for bladder cancer diagnosis and monitoring. Front Cell Dev Biol 10:892067","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"4270_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1159\/000531443","volume":"107","author":"JP Struck","year":"2023","unstructured":"Struck JP et al (2023) The role of urine and washing cytology in primary transurethral resection of bladder tumours. Urol Int 107(8):792\u2013800","journal-title":"Urol Int"},{"issue":"1","key":"4270_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.30699\/ijp.2021.528171.2646","volume":"17","author":"MR Kalantari","year":"2022","unstructured":"Kalantari MR et al (2022) Direct smear versus liquid-based cytology in the diagnosis of bladder lesions. Iran J Pathol 17(1):56\u201364","journal-title":"Iran J Pathol"},{"issue":"7","key":"4270_CR27","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3390\/cancers13071650","volume":"13","author":"M Charpentier","year":"2021","unstructured":"Charpentier M et al (2021) Noninvasive urine-based tests to diagnose or detect recurrence of bladder cancer. Cancers (Basel) 13(7):1650","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4270_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00432-024-05613-9","volume":"150","author":"C Jiang","year":"2024","unstructured":"Jiang C et al (2024) Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers. J Cancer Res Clin Oncol 150(3):169","journal-title":"J Cancer Res Clin Oncol"},{"key":"4270_CR29","doi-asserted-by":"publisher","DOI":"10.3310\/hta14040","author":"G Mowatt","year":"2010","unstructured":"Mowatt G et al (2010) Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess. https:\/\/doi.org\/10.3310\/hta14040","journal-title":"Health Technol Assess"},{"issue":"7","key":"4270_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jama.293.7.810","volume":"293","author":"HB Grossman","year":"2005","unstructured":"Grossman HB et al (2005) Detection of bladder cancer using a point-of-care proteomic assay. JAMA 293(7):810\u2013816","journal-title":"JAMA"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04270-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04270-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04270-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T14:57:07Z","timestamp":1739372227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04270-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["4270"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04270-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was approved by the ethics committee of the Institutional Review Board of Taichung Veterans General Hospital (IRB: CF23221C) and conducted from June 2023 to June 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participates were informed the consent participate, which was approved by the ethics committee of the Institutional Review Board of Taichung Veterans General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Tien-Jen Liu, Shih-Wen Hsu, Cheng-Hung Yeh, and Ming-Yu Lin are employees of AIxMed, Inc. and hold stock in AIxMed, Inc\u201d. Besides, the other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}